Baird Medical and ExcelFin Acquisition Corp Announce Strategic Update to Business Combination Terms to Reinforce Long-Term Value Creation Opportunity and Alignment with Shareholders
* Baird Medical agreed to subject 30% of its shares to be received in the transaction to an earnout at a$12.50 trading price * Minimum cash condition of $15 million has been waived, cementing certainty and expediency to our transaction close * Upon closing, Baird Medical is expected to trade...
ExcelFin Acquisition Corp. Announces Adjournment of Special Meeting
NEW YORK, Oct. 17, 2023 /PRNewswire/ -- ExcelFin Acquisition Corp. ("we", "us", "our", or the "Company"), today announced that the Special Meeting originally scheduled forOctober 18, 2023 (the "Special Meeting") is being adjourned to October 20, 2023. At the Special Meeting, the Company's stockho...
Baird Medical, A Leading Developer and Provider of Microwave Ablation (MWA) Medical Devices in China, to be Publicly Listed on NASDAQ through a Proposed Business Combination with ExcelFin Acquisition Corp.
* Ranked first among MWA medical device providers in thyroid nodule and breast lump treatment with approximately 35% market share inChina[1] * Extensive distribution network with over 430 hospitals penetrated and national coverage across 21 provinces, municipalities, and autonomous regions in ...
